New Portfolio Jun 2024 - New Portfolio

Craig Kopecky

New Portfolio Jun 2024
Individual Investor
Ranked #187,372 out of 828,236 TipRanks' Investors
Success Rate
56%
39 out of 69
profitable transactions
Average Return
33.45%
Average return
per transaction
Share this portfolio:

Portfolio Gain

1-Month Return▼ 1.66%
6-Month Return▲ 145.04%
12-Month Return▲ 134.95%
YTD Return▲ 149.85%
Total Return▲ 104.61%

Best Trade

Opened at
Closed at-
Gain▲ 575.60%

Bio

Mainly Tech, biotech, and a fewPharm (stick with what you know)

Performance

92.97%0-92.97%
▲ 0.80%
▼ 0.87%
▲ 7.76%
Apr 2025
▲ 11.64%
▲ 6.28%
▲ 4.41%
May 2025
▲ 9.25%
▲ 5.14%
▲ 2.72%
Jun 2025
▲ 7.60%
▲ 2.30%
▲ 13.32%
Jul 2025
▲ 2.76%
▲ 2.05%
▲ 5.55%
Aug 2025
▲ 12.88%
▲ 3.56%
▲ 92.97%
Sep 2025
▲ 10.96%
▲ 2.38%
▲ 11.57%
Oct 2025
▼ 5.65%
▼ 1.47%
▼ 6.63%
Nov 2025
TipRanks AverageS&P 500Investor Portfolio
▲ 0.80%▼ 0.87%▲ 7.76%
▲ 11.64%▲ 6.28%▲ 4.41%
▲ 9.25%▲ 5.14%▲ 2.72%
▲ 7.60%▲ 2.30%▲ 13.32%
▲ 2.76%▲ 2.05%▲ 5.55%
▲ 12.88%▲ 3.56%▲ 92.97%
▲ 10.96%▲ 2.38%▲ 11.57%
▼ 5.65%▼ 1.47%▼ 6.63%

Recent Activity

Company Name
% of Portfolio
Return
No. of Transactions
Last Transaction
Date
Mesoblast
0%
▼ 23.60%
1
Open
Oct 09, 2025
Mercadolibre
0%
▼ 5.72%
1
Open
Oct 05, 2025
HIVE Digital Technologies
0%
▲ 28.42%
1
Open
Aug 26, 2025
Intuitive Surgical
0%
▲ 17.50%
1
Open
Aug 18, 2025
Amazon
▲ 15.36%
4
Close
Aug 14, 2025
GeneDx Holdings
▲ 8.97%
2
Close
Aug 14, 2025
GRAIL Inc
▲ 115.22%
2
Close
Aug 03, 2025
Alphabet Class A
▲ 17.15%
2
Close
Jul 27, 2025
Navitas Semiconductor
0%
▲ 35.45%
1
Open
Jul 11, 2025
Salesforce
0%
▼ 7.19%
1
Open
Jun 18, 2025
BWX Technologies
0%
▲ 62.77%
1
Open
May 16, 2025
DaVita
0%
▼ 14.52%
1
Open
May 07, 2025
ACADIA Pharmaceuticals
0%
▲ 59.62%
1
Open
May 07, 2025
Credo Technology Group Holding Ltd
0%
▲ 196.21%
1
Open
May 02, 2025
CoreWeave
0%
▲ 51.91%
1
Open
May 02, 2025
Airbnb
0%
▼ 1.71%
1
Open
Apr 26, 2025
Global Payments
0%
▲ 2.14%
1
Open
Apr 26, 2025
Regeneron
▼ 16.49%
2
Close
Apr 24, 2025
TSMC
▼ 16.15%
3
Close
Apr 17, 2025
AppLovin
0%
▲ 112.29%
1
Open
Apr 03, 2025